Asia Spotlight: China Probe Reveals Widespread Data Violations At Major Study Centers

Severe adverse events left unreported, critical data gone missing, subject drugs substituted to pass bioequivalent testing are just some of the wrongdoings disclosed by the China FDA in a rare new report on regulatory transgressions.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from China

More from Asia